Truvian Stock
HealthTechLooking to sell Truvian stock or options?
Truvian has developed an automated blood testing and diagnostic technology that offers a convenient and cost-effective alternative to traditional off-site laboratories. Their technology integrates clinical chemistries, immunoassays, and hematology assays into a single instrument, providing lab-accurate results more quickly for a range of health tests. This innovation allows healthcare professionals to access comprehensive and easy-to-understand lab test reports and insights, making routine health testing both practical and affordable.
Fanjul Capital, Domain Associates, DNS Capital, Medical Excellence Capital, Wasson Enterprise, XB Ventures, Embark Ventures, TYH Ventures, VIDANT Capital, CONNECT (San Diego).